Rhone-Poulenc warns on profits
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.MAGNUS GRIMOND
Rhone-Poulenc, the French chemicals and pharmaceuticals giant, yesterday sent a shudder through the Paris stock market after it warned of lower than expected profits for this year. Shares in the group slid 6.20 francs to Ff100.80 following the announcement - which pinned most of the blame on the economic downturn in the fourth quarter, the French transport strikes and the need to contribute to government efforts to stem the national deficit.
The company said that the pounds 1.8bn acquisition of Fisons by its US subsidiary, Rhone-Poulenc Rorer, would also result in exceptional charges, although these had been foreseen last year.
Brokers saw the warning as a possible prelude to further bad news from France's major companies in the wake of the recent economic squalls. But the main CAC-40 index closed little changed, ending down just 0.27 points at 1,916.29.
Rhone-Poulenc had previously forecast a significant rise in 1995 results, even talking of "double-digit" growth earlier in the year. But yesterday it said: "Based on the first indications of activities in the fourth quarter, and without taking account of possible effects of the Fisons integration, the group is now expecting lower results than previously forecast."
Besides the downturn in the economy from last September, the company said that the transport strike at the end of last year and the exceptional contributions to the social security deficit, had led to the change in forecast. It also said it would be increasing "slightly" the amount of provisions for last year.
A source close to Rhone-Poulenc said: "The 1995 net attributable profit will be at the same level as the 1994 profit. Ff2bn is a maximum." Even at this lower level, the figure will be higher than the Ff1.92bn struck in 1994. Net profits increased 71 per cent to Ff1.96bn for the first nine months of 1995, despite a 17 per cent fall in the third quarter due to higher provisons and tax charges.
The company source said that the downturn in the economy would cost the company Ff300m, with the three week public sector strike - which forced closure of some chemicals production units in the Rhone-Alpes region - adding a further Ff200m.
Meanwhile, the pharmaceutical industry is in negotiations with the government over a Ff2.5bn contribution being sought by the government from the industry to help cut the social security deficit.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments